The DOI matches its Crossref record.
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Abstract
The subunit composition and pharmacological regulation of rat neuronal nicotinic cholinergic receptors were assessed. Specific immunoprecipitation was determined in solubilized rat brain homogenates using [3H]cytisine, a high affinity agonist at nicotinic receptors, in conjunction with polyclonal antisera generated against nonhomologous domains of the various subunits comprising this receptor class. In all brain regions tested, only antisera generated against the alpha 4 and beta 2 subunits were able to immunoprecipitate specifically receptors labeled by [3H]cytisine. Thus, these sera were further characterized in order to validate and optimize their use in the immunoprecipitation protocol. Preincubation of solubilized receptors from rat forebrain with antisera generated against the alpha 2, alpha 3, alpha 5, beta 3, or beta 4 subunits did not decrease the amount of precipitable alpha 4 or beta 2 subunit. On the other hand, when either anti-alpha 4 or anti-beta 2 serum was used to immunoprecipitate solubilized receptors from rat forebrain, the supernatants contained little if any remaining receptors that could be specifically precipitated by either antibody. Because these antisera do not cross-react, the data indicate that alpha 4 and beta 2 subunits are associated with each other in at least one neuronal nicotinic receptor subtype that has high affinity for agonists. Moreover, these results imply that all alpha 4 subunits that are labeled by [3H]cystisine are coupled to beta 2 subunits. We also present evidence that the alpha 4/beta 2 subtype characterized in this report is significantly increased in the cortex of rats chronically treated with nicotine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, nicotine induced increases in nAChR, termed “upregulation”, are conferred by a specific microdomain that is in the β2-subunit 34 and thus this upregulation is confined to nAChR that contain the β2-subunit4, 19, 31, 35-38.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [19]
In the citing paper
“Immunoprecipitation with subunit-selective antibodies and studies in genetic knockout models demonstrate that chronic administration of nicotine increases predominantly the ␣42 subtype of nAChRs in rodent brain (Flores et al., 1992;Mao et al., 2008;Moretti et al., 2010;Marks et al., 2011)”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Flores et al., 1992
Citations
Cited by
Sorted by citations
Items 701–800 of 880
Han, X., Zhou, N., Hu, H., Li, X., & Liu, H. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00265-2 · Cited by 10
Nakauchi, S., & Sumikawa, K. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.07.014 · Cited by 10
Wall, A., Gong, Z., Johnson, A. E., Meyerson, B. J., & Zhang, X. (2000) · Psychopharmacology · doi:10.1007/s002130050041 · Cited by 10
Alcohol preference: association with reduced striatal nicotinic receptors
Tizabi, Y. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.4.318 · Cited by 10
Nicotinic receptor dependent regulation of cough and other airway defensive reflexes
Tao, M., Liu, Q., Miyazaki, Y., & Canning, B. J. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.101810 · Cited by 10
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50043-6 · Cited by 10
Henderson, P. T., Boone, E. K., & Schuster, G. B. A. (2002) · Helvetica Chimica Acta · doi:10.1002/1522-2675(200201)85:1 · Cited by 15
The Role of Desensitization in CNS Nicotinic Receptor Function
Lippiello, P. M., Bencherif, M., & Prince, R. J. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_10 · Cited by 10
Expression of the nicotinic acetylcholine receptor α4 subunit mRNA in the rat cerebellar cortex
Nakayama, H., Shioda, S., Nakajo, S., Ueno, S., & Nakai, Y. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00784-8 · Cited by 10
Viberg, H. (2004) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 10
The Subunit Specific Effects of Novel Anabaseine-Derived Nicotinic Agents
Papke, R. L., de Fiebre, C. M., Kem, W. R., & Meyer, E. M. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_35 · Cited by 10
Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms
Brynildsen, J. K., & Blendy, J. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108480 · Cited by 11
Messi, E., Pimpinelli, F., Andrè, V., Rigobello, C., Gotti, C., & Maggi, R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.025 · Cited by 9
Moser, N., Wevers, A., Lorke, D. E., Reinhardt, S., Maelicke, A., & Schröder, H. C. (1996) · Cell and Tissue Research · doi:10.1007/s004410050616 · Cited by 9
Hall, B. J., Pearson, L. S., & Buccafusco, J. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.09.009 · Cited by 9
Foll, B. L., Chefer, S. I., Kimes, A. S., Stein, E. A., Goldberg, S. R., & Mukhin, A. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4250-9 · Cited by 9
Zhang, Y., Yanagawa, Y., & Saito, Y. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00852.2015 · Cited by 9
Tuan, E. W., Horti, A. G., Olson, T. T., Gao, Y., Stockmeier, C. A., Al‐Muhtasib, N., Dalley, C. B., Lewin, A. E., Wolfe, B. B., Sahibzada, N., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099978 · Cited by 9
Moretti, M., Fasoli, F., Gotti, C., & Marks, M. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13896 · Cited by 8
Wecker, L., & Rogers, C. Q. (2003) · Neurochemical Research · doi:10.1023/a:1022892400362 · Cited by 9
Sumithran, S. P., Crooks, P. A., Xu, R., Zhu, J., Deaciuc, A. G., Wilkins, L. H., & Dwoskin, L. P. (2005) · The AAPS Journal · doi:10.1208/aapsj070119 · Cited by 9
Lin, N., He, Y., Arnerić, S. P., & Sullivan, J. P. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00183-t · Cited by 9
Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine
Rao, T. S., Sacaan, A. I., Menzaghi, F., Reid, R. T., Adams, P. B., Correa, L. D., Whelan, K. T., & Vernier, J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.038 · Cited by 9
Luetje, C. W., Maddox, F. N., & Harvey, S. C. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13284-1 · Cited by 9
Pandey, S. C., Xu, T., & Zhang, D. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00172-x · Cited by 9
Effects of pre-and neonatal nicotine exposure in rodents: inconsistent evidence
Sobrian, S. K., & Holson, R. R. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.251 · Cited by 8
Jalaiei, A., Asadi, M. R., Daneshmandpour, Y., Rezazadeh, M., & Ghafouri‐Fard, S. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16200 · Cited by 8
Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure
Zambrano, C. A., Short, C. A., Salamander, R. M., Grady, S. R., & Marks, M. J. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.111 · Cited by 8
Structural characterization and agonist binding to human α4β2 nicotinic receptors
daCosta, C. J. B., Sturgeon, R. M., Hamouda, A. K., Blanton, M., & Baenziger, J. E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.026 · Cited by 8
Beani, L., Antonelli, T., Tomasini, M. C., Marani, L., & Bianchi, C. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00155-6 · Cited by 8
Yeh, J. J., Yasuda, R. P., Dávila‐García, M. I., Xiao, Y., Ebert, S. N., Gupta, T., Kellar, K. J., & Wolfe, B. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00259.x · Cited by 8
Chen, Y.-H., Kuo, T., Huang, E. Y., Chou, Y., Chiang, Y. H., Hoffer, B. J., & Miller, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24245 · Cited by 7
Translational Approaches to Medication Development
Bartlett, S. E., & Heilig, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-28720-6_132 · Cited by 7
Lewis, J. A., Yakel, J. L., & Pandya, A. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161201145648 · Cited by 7
Recombinant cellular model system for human muscle-type nicotinic acetylcholine receptor α12β1δε
Brockmöller, S., Seeger, T., Worek, F., & Rothmiller, S. (2023) · Cell Stress and Chaperones · doi:10.1007/s12192-023-01395-0 · Cited by 8
Neuronal Nicotinic Acetylcholine Receptors: From Biophysical Properties to Human Diseases
Buisson, B., Picard, F., & Bertrand, D. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_11 · Cited by 7
Bombieri, G., Meneghetti, F., Artali, R., Tasso, B., Boido, C. C., & Sparatore, F. (2008) · Chemistry and Biodiversity · doi:10.1002/cbdv.200890174 · Cited by 8
Zambrano, C. A., Salamander, R. M., Collins, A. C., Grady, S. R., & Marks, M. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192542 · Cited by 7
Debom, R. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000396 · Cited by 7
Preclinical Studies of the Potent and Selective Nicotinic α4β2 Receptor Ligand VMY-2-95
Kong, H., Song, J.-K., Yenugonda, V. M., Zhang, L., Tian, S., Cheema, A. K., Kong, Y., Du, G., & Brown, M. L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5003569 · Cited by 7
Simmons, S. J., Gentile, T. A., Mo, L., Tran, F. H., Ma, S., & Muschamp, J. W. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.053 · Cited by 7
Yoshii, M., Watabe, S., Murashima, Y. L., Nukada, T., Shiotani, T., & Nishizaki, T. (2001) · Psychogeriatrics · doi:10.1111/j.1479-8301.2001.tb00071.x · Cited by 7
Nicotine decreases agrin signaling and acetylcholine receptor clustering in C2C12 myotube culture
Ferayorni, A. J., Gunville, C. F., & Grow, W. A. (2004) · Journal of Neurobiology · doi:10.1002/neu.20012 · Cited by 6
Henningfield, J. E., Keenan, R. M., & Clarke, P. B. S. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_8 · Cited by 7
Pierucci, M., Pitruzzella, A., Valentino, M., Zammit, C., Muscat, R., Benigno, A., & Giovanni, G. D. (2011) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 6
Nicotinic Signaling in Development
Fernandes, C., Lozada, A. F., & Berg, D. K. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_6 · Cited by 6
Ueda, M., Iida, Y., Yoneyama, T., Kawai, T., Ogawa, M., Magata, Y., & Saji, H. (2010) · Synapse · doi:10.1002/syn.20819 · Cited by 7
Roll, R. L., Jones, T. A., Benowitz, N. L., & Morley, B. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90377-y · Cited by 6
Vadász, C., Saito, M., O’Brien, D., Zavadil, J., Morahan, G., Chakraborty, G., & Wang, R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9250-4 · Cited by 6
Pandey, S. C. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12817-2 · Cited by 6
Wilkins, L. H., Miller, D. K., Ayers, J. T., Crooks, P. A., & Dwoskin, L. P. (2005) · The AAPS Journal · doi:10.1208/aapsj070490 · Cited by 6
Kini, R. M., & Koh, C. Y. (2025) · Toxins · doi:10.3390/toxins17080364 · Cited by 8
Müderrisoğlu, A., Babaoğlu, E., Korkmaz, E. T., Kalkışım, S., Karabulut, E., Emri, S., & Babaoglu, M. O. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.812715 · Cited by 6
Homeostatic plasticity in Drosophila central neurons, and implications in human diseases
Ping, Y., & Tsunoda, S. (2012) · Fly · doi:10.4161/fly.20775 · Cited by 5
Dougherty, J. J., Wu, J., Mehta, T. K., Brown, B. R., & Nichols, R. A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9557-9 · Cited by 5
Fox-Loe, A. M., Dwoskin, L. P., & Richards, C. I. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_7 · Cited by 5
α4β2 nicotinic acetylcholine receptors intrinsically influence body weight in mice
Dezfuli, G., Olson, T. T., Martin, L. M., Keum, Y., Siegars, B., Desai, A., Uitz, M., Sahibzada, N., Gillis, R. A., & Kellar, K. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107921 · Cited by 5
Preclinical and Clinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_18 · Cited by 5
Agonists and Antagonists of Nicotinic Acetylcholine Receptors
Arnerić, S. P., & Holladay, M. W. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_16 · Cited by 5
Abdrakhmanova, G. R., Carroll, F. I., Damaj, M. I., & Martin, B. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.007 · Cited by 5
Re-Evaluation of Nicotinic Acetylcholine Receptors in Rat Brain by a Tissue-Segment Binding Assay
Wang, M., Yoshiki, H., Anisuzzaman, A. S. M., Uwada, J., Nishimune, A., Lee, K., Taniguchi, T., & Muramatsu, I. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00065 · Cited by 5
Nicotinic Cholinergic Receptors as Targets in Pain Control
Damaj, M. I., & Flores, C. M. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.sec2 · Cited by 5
Jones, I. W., Bolam, J. P., & Wonnacott, S. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4615-0715-4_14 · Cited by 5
Rossant, C. J., Lindstrom, J. M., & Loring, R. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041368.x · Cited by 5
Villeneuve, G., Cécyre, D., Jeune, H. L., Drouin, M., Lan, R., & Quirion, R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00728-5 · Cited by 5
Pubill, D., Garcia-Ratés, S., Camarasa, J., & Escubedo, E. (2011) · Pharmaceuticals · doi:10.3390/ph4060822 · Cited by 5
Hemodynamic Effects of the Light Stabilizer Tinuvin 770 in Dogs In Vivo
Krepuska, M., Hubay, M., Zima, E., Kovacs, A., Kékesi, V., Kalász, H., Szilágyi, B., Merkely, B. P., & Sótonyi, P. (2018) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501812010088 · Cited by 4
Preclinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_17 · Cited by 4
Human Brain Imaging of Acetylcholine Receptors
Toyohara, J., Sakata, M., & Ishiwata, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418677-4.00006-3 · Cited by 4
Synthesis of H-bonding probes of α7 nAChR agonist selectivity
Wang, J., Papke, R. L., & Horenstein, N. A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.044 · Cited by 4
The analgesic potential of compounds acting at acetylcholine receptors
Decker, M. W. (1999) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-199910000-00018 · Cited by 4
Brammar, W. J. (1996) · Elsevier eBooks · doi:10.1016/b978-012184450-9/50009-0 · Cited by 4
Braunscheidel, K. M., Voren, G., Fowler, C. D., Lu, Q., Kuryatov, A., Cameron, M. D., Ibáñez-Tallon, I., Lindstrom, J. M., Kamenecka, T. M., & Kenny, P. J. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1459098 · Cited by 3
Ogunjirin, A. E., Fortunak, J., Brown, L. L., Xiao, Y., & Dávila‐García, M. I. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1705-z · Cited by 3
Solt, K., Kelly, E. W., Cotten, J. F., & Raines, D. E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c5f689 · Cited by 3
Prenatal nicotine exposure increases hyperventilation in α4-knock-out mice during mild asphyxia
Avraam, J., Cohen, G., Drago, J., & Frappell, P. B. (2015) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2015.01.006 · Cited by 3
Burghaus, L., Schütz, U., Simonnet, K., Krempel, U., Lindstrom, J. M., & Schröder, H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01605-6 · Cited by 3
Soriano, E., Marco, J. L., Colmena, I., & Gandı́a, L. (2009) · Molecular Diversity · doi:10.1007/s11030-009-9161-9 · Cited by 3
López‐Hernández, G. Y., Biaggi-Labiosa, N. M., Torres-Cintrón, A., Ortiz‐Acevedo, A., & Lasalde‐Dominicci, J. A. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-008-9293-y · Cited by 3
Dopamine-dependent modulation of rat globus pallidus excitation by nicotine acetylcholine receptors
Ríos, A., Barrientos, R., Alatorre, A., Delgado, A., Pérez‐Capistran, T., Chuc-Meza, E., Garcı́a-Ramı́rez, M., & Querejeta, E. (2015) · Experimental Brain Research · doi:10.1007/s00221-015-4491-6 · Cited by 3
Rogers, S. W., & Gahring, L. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143319 · Cited by 3
Beach, W., Miller, R., & McCurdy, C. R. (1999) · CRC Press eBooks · doi:10.1201/9781420048650.ch11 · Cited by 3
Regulation of Neuronal Nicotinic Receptors in Primary Cultures
Dávila‐García, M. I., Xiao, Y., Houghtling, R. A., Qasba, S. S., Flores, C. M., & Kellar, K. J. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_12 · Cited by 3
Neuronal Nicotinic Receptors: One Hundred Years of Progress
Kellar, K. J., & Xiao, Y. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn004 · Cited by 3
Ankarberg, E. H. (2003) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3
Biochemical Measures of Nicotinic Receptor Desensitization
Marks, M. J., Grady, S. R., Robinson, S. F., Bullock, A. E., & Collins, A. C. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7445-8_9 · Cited by 3
Alpha 7 nicotinic acetylcholine receptors: Molecular pharmacology and role in neuroprotection
van Rensburg, R., & Chazot, P. (2008) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2008.05.001 · Cited by 2
Guandalini, L., Dei, S., Manetti, D., Romanelli, M. N., Scapecchi, S., Teodori, E., & Varani, K. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01234-x · Cited by 2
Aplin, A. E., & Wonnacott, S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90276-3 · Cited by 2
Wildeboer, K. M. (2005) · Cited by 2
Bavan, S., Kim, C. H., Henderson, B. J., & Lester, H. A. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.114769 · Cited by 2
Avraam, J., Cummings, K. J., & Frappell, P. B. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2016 · Cited by 2
Genetic Regulation of Nicotine-Related Behaviors and Brain Nicotinic Receptors
Stitzel, J. A., Leonard, S. S., & Collins, A. C. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_22 · Cited by 2
Nicotinic Receptors in the Central Nervous System
Ifune, C. K., & Steinbach, J. H. (1996) · Springer eBooks · doi:10.1007/978-1-4613-1143-0_8 · Cited by 2
Torrão, A. D. S., Ferro, E. S., Lindstrom, J. M., & Britto, L. R. G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02132-6 · Cited by 2
Rationale and prospects for drugs that target nicotinic acetylcholine receptors
Wevers, A., & Woodruff‐Pak, D. S. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7867-8_4 · Cited by 2
The Nicotinic Cholinergic System and ß-Amyloidosis
COURT, J. A., Lloyd, S. R., Perry, R. H., Griffiths, M., Morris, C. M., Johnson, M. K., McKeith, I. G., & Perry, E. K. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_40 · Cited by 2
Nicotinic Receptors as a new Target for Treatment of Alzheimer’s Disease
Nordberg, A. K., Svensson, A., Berglund, U. W., Bud, L., Marutle, A., Miao, H., Gorbounova, O., Bednar, I., Hellström‐Lindahl, E., & Zhang, X. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_66 · Cited by 2
An Investigation of CYP2B in Rat Brain: Regulation and Role in Drug and Toxin Response
Khokhar, J. Y. (2012) · TSpace (University of Toronto) · Cited by 2
NEUROTRANSMITTERS AND RECEPTORS AS THE TARGETS FOR ADDICTION TREATMENT: A SHORT REVIEW
Bonam, S. R., Kumar, M. S. A., Rao, N., Babu, A. N., Rao, N. R., & Manjunathan, J. (2013) · Cited by 1
Metadata
- Authors
- Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J.
- Affiliations
- Georgetown University Medical Center (US)
- University of Colorado Denver (US)
- Georgetown University (US)
- ORCID
- Kellar, K J
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 41
- Issue
- 1
- Pages
- 31-37
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2116249462
- Cited by
- 880
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 18 · 2015: 25 · 2014: 25 · 2013: 22 · 2012: 21
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01ag009884-05, 5r01da006486-10, 5r01ns011549-24)
- National Institute on Aging (AG 09884)
- National Institute on Drug Abuse (DA-06486)
- National Institute of Neurological Disorders and Stroke (NS11549)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, receptor subunit composition, chronic nicotine treatment, receptor up-regulation, rat cortex, forebrain, neuronal nicotinic receptors
- MeSH terms
- Quinolizidine Alkaloids, Alkaloids, Animals, Antibodies, Azocines, Brain, Kinetics, Male, Nicotine, Precipitin Tests, Quinolizines, Rats, Inbred Strains, Receptors, Nicotinic, Time Factors, Tritium, Up-Regulation, Macromolecular Substances, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review